Site for A Multi-Center Prospective Randomized Controlled Trial Comparing the Safety and Effectiveness of prodisc C SK and prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Cervical Disc Disease
  • Age: Between 18 Year(s) - 69 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects with diagnosis of radiculopathy or myelopathy with radiculopathy of the cervical spine, with pain, paresthesias or paralysis in a specific nerve root distribution C3 through C7, including at least one of the following:

You may not be eligible for this study if the following are true:

    1. Subjects with an active systemic infection or infection at the operative site
    2. Subjects with history of or anticipated treatment for active systemic infection, including HIV or Hepatitis C.
    3. Subjects who have more t


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.